Prognostic factors in ovarian cancer: current evidence and future prospects
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference153 articles.
1. Cancer statistics, 2003;Jemal;CA Cancer J Clin,2003
2. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma;Trimbos;J Natl Cancer Inst,2003
3. Should therapy of ovarian cancer patients be individualized based on underlying genetic defects?;Mills;Clin Cancer Res,1999
4. HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancer;Konecny;Breast Cancer Res Treat,2001
5. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The CancerGrid experience: Metadata-based model-driven engineering for clinical trials;Science of Computer Programming;2014-09
2. Increased COX-2 expression in patients with ovarian cancer;AFRICAN JOURNAL OF BIOTECHNOLOGY;2011-10-26
3. Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis;British Journal of Cancer;2011-04
4. Targeting the EGF Receptor for Ovarian Cancer Therapy;Journal of Oncology;2010
5. Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis;British Journal of Cancer;2009-06-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3